Pas encore membre de TradeKey.com? Inscrivez-vous pour vous connecter avec 9 millions d'importateurs et exportateurs.
Rejoignez-le maintenant c'est gratuit |
BOOK A CALL
Book Call On Your Favorite Time

By Signing Up. I agree to TradeKey.com Terms of Use, Privacy Policy, IPR and receive emails related to our services

Contact Us


Shanghai Yudiao Chemistry Technology Co., Ltd

Building A, NO.688,Qiushi Road,Jinshan District,Shanghai,shanghai,China China

Membre gratuit
Contacter maintenant
Voir le numéro de téléphone
Voir le numéro de mobile
Accueil Société Shanghai Yudiao Chemistry Technology Co., Ltd Produits

Produits: 15

Raltegravir (free base) API

Raltegravir (MK-0518) is a potent inhibitor of human immunodeficiency virus (HIV) integrase and is clinically effective against viruses resistant to o

Contacter maintenant
Raltegravir k salt

871038-72-1, raltegravir, raltegravir K salt, N-(2-(4-(4-fluorobenzylcarbamoyl)-5-hydroxy-1-methyl-6-oxo-1, 6-dihydropyrimidin-2-yl)propan-2-yl)-5-met

Contacter maintenant
3-iodo-6-nitro-1-(tetrahydropyran-2-yl)-1H-indazole

Axitinib is an investigational drug being developed by Pfizer for treating advanced renal cell carcinoma (ARCC) and hepatocellular carcinoma.The drug

Contacter maintenant
(E)-6-nitro-3-(2-(pyridin-2-yl)vinyl)-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole

Axitinib is an investigational drug being developed by Pfizer for treating advanced renal cell carcinoma (ARCC) and hepatocellular carcinoma.

Contacter maintenant
(E)-3-(2-(pyridin-2-yl)vinyl)-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-6-amine

Axitinib is an investigational drug being developed by Pfizer for treating advanced renal cell carcinoma (ARCC) and hepatocellular carcinoma.The drug

Contacter maintenant
(E)-6-iodo-3-(2-(pyridin-2-yl)vinyl)-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole

Axitinib is an investigational drug being developed by Pfizer for treating advanced renal cell carcinoma (ARCC) and hepatocellular carcinoma.The drug

Contacter maintenant
(E)-N-methyl-2-(3-(2-(pyridin-2-yl)vinyl)-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-6-ylthio)benzamide

Axitinib is an investigational drug being developed by Pfizer for treating advanced renal cell carcinoma (ARCC) and hepatocellular carcinoma.The drug

Contacter maintenant
2-mercapto-N-methylbenzamide

Axitinib is an investigational drug being developed by Pfizer for treating advanced renal cell carcinoma (ARCC) and hepatocellular carcinoma.

Contacter maintenant
Axitinib API

Axitinib is an investigational drug being developed by Pfizer for treating advanced renal cell carcinoma (ARCC) and hepatocellular carcinoma.

Contacter maintenant
Masitinib API

In vitro, masitinib had greater activity and selectivity against KIT than imatinib, inhibiting recombinant human wild-type KIT with an half inhibitory

Contacter maintenant
1-Methyl-5-nitro-1H-benzimidazole-2-butanoic acid ethyl ester

Bendamustine was first synthesized in 1963 by Ozegowski and Krebs in East Germany (the former German Democratic Republic).

Contacter maintenant
Bendamustine HCl API

Bendamustine was first synthesized in 1963 by Ozegowski and Krebs in East Germany (the former German Democratic Republic).

Contacter maintenant
(S)-tert-butyl 3-oxo-1-phenylpropylcarbamate

A panel of four CCR5 monoclonal antibodies (mAbs) recognizing different epitopes on CCR5 was examined in CCR5-mediated cell-cell fusion assay

Contacter maintenant
Maraviroc API

A panel of four CCR5 monoclonal antibodies (mAbs) recognizing different epitopes on CCR5 was examined in CCR5-mediated cell-cell fusion assay

Contacter maintenant
2-Amino-2-methylpropane nitrile

Raltegravir (MK-0518) is a potent inhibitor of human immunodeficiency virus (HIV) integrase and is clinically effective against viruses resistant to o

Contacter maintenant

Contacter ce vendeur

To:
Mr. James < Shanghai Yudiao Chemistry Technology Co., Ltd >
Je veux savoir: